4//SEC Filing
Lin Kenneth 4
Accession 0001493152-24-024125
CIK 0001815974other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:23 PM ET
Size
19.9 KB
Accession
0001493152-24-024125
Insider Transaction Report
Form 4
Lin Kenneth
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-13+41,667→ 41,667 totalExercise: $2.10Exp: 2034-06-12→ Common Stock (41,667 underlying) - Award
Stock Option (right to buy)
2024-06-13+2,482→ 2,482 totalExercise: $2.10Exp: 2034-06-12→ Common Stock (2,482 underlying)
Footnotes (2)
- [F1]These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant
- [F2]These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders
Documents
Issuer
Anebulo Pharmaceuticals, Inc.
CIK 0001815974
Entity typeother
Related Parties
1- filerCIK 0001770623
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:23 PM ET
- Size
- 19.9 KB